*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T420X5A - Adverse effect of hydantoin derivatives, initial encounter - as a primary diagnosis code | T420X5A - Adverse effect of hydantoin derivatives, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.13 | |
| Readmission Rate (%) | 22.28 | |
| Unplanned Readmission Rate (%) | 12.52 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 71,748 | |
| Total Hospitalizations with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 435 | |
| DRG Share of Total Hospitalizations | 0.22 | |
| % of Total ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter in DRG | 69.94 | |
| Avg LOS at DRG | 2.93 | |
| Avg LOS with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 3.45 | |
| Readmission Rate at DRG | 33.86 | |
| Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 18.87 | |
| Unplanned Readmission Rate at DRG | 10.34 | |
| Unplanned Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 11.32 | |
| Total Medicare payments at DRG | $313,351,773 | |
| Total Medicare payments with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $1,866,984 | |
| Total Medicare payment per Day at DRG | $1,489 | |
| Total Medicare payment per Day with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $1,244 | |
| Total Medicare payment per Hospitalization at DRG | $4,367 | |
| Total Medicare payment per Hospitalization with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $4,292 | |
| Total Medicare Charges at DRG | $1,750,048,705 | |
| Total Medicare Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $10,155,713 | |
| Avg Charges at DRG | $24,392 | |
| Avg Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $23,346 | |
| Mortality Rate at DRG | 0.22 | |
| Mortality Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | NA | |
| SNF Discharge Rate at DRG | 7.61 | |
| SNF Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 26.9 | |
| Home Discharge Rate at DRG | 51.88 | |
| Home Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 40.46 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 122,730 | ||||
| Total Hospitalizations with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 881 | ||||
| DRG Share of Total Hospitalizations | 0.37 | ||||
| % of Total ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter in DRG | 8.64 | ||||
| Avg LOS at DRG | 7.61 | ||||
| Avg LOS with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 4.63 | ||||
| Readmission Rate at DRG | 21.31 | ||||
| Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 19.65 | ||||
| Unplanned Readmission Rate at DRG | 14.13 | ||||
| Unplanned Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 10.94 | ||||
| Total Medicare payments at DRG | $1,397,885,220 | ||||
| Total Medicare payments with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $5,380,936 | ||||
| Total Medicare payment per Day at DRG | $1,497 | ||||
| Total Medicare payment per Day with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $1,320 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,390 | ||||
| Total Medicare payment per Hospitalization with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $6,108 | ||||
| Total Medicare Charges at DRG | $4,175,290,309 | ||||
| Total Medicare Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $28,407,160 | ||||
| Avg Charges at DRG | $34,020 | ||||
| Avg Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $32,244 | ||||
| Mortality Rate at DRG | 0.28 | ||||
| Mortality Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 21.64 | ||||
| SNF Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 34.85 | ||||
| Home Discharge Rate at DRG | 28.06 | ||||
| Home Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 30.99 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 448 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter in DRG | 4.39 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 7.94 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 26.23 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 19.61 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $5,502,647 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $1,547 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $12,283 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $31,945,571 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $71,307 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 5.8 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 43.08 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 15.18 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 149: DYSEQUILIBRIUM | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 57,930 | ||||
| Total Hospitalizations with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 226 | ||||
| DRG Share of Total Hospitalizations | 0.18 | ||||
| % of Total ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter in DRG | 2.22 | ||||
| Avg LOS at DRG | 2.53 | ||||
| Avg LOS with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 3.14 | ||||
| Readmission Rate at DRG | 10.35 | ||||
| Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 12.96 | ||||
| Unplanned Readmission Rate at DRG | 6.04 | ||||
| Unplanned Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 9.26 | ||||
| Total Medicare payments at DRG | $235,356,849 | ||||
| Total Medicare payments with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $954,401 | ||||
| Total Medicare payment per Day at DRG | $1,603 | ||||
| Total Medicare payment per Day with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $1,344 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,063 | ||||
| Total Medicare payment per Hospitalization with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $4,223 | ||||
| Total Medicare Charges at DRG | $1,526,468,039 | ||||
| Total Medicare Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $6,341,596 | ||||
| Avg Charges at DRG | $26,350 | ||||
| Avg Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $28,060 | ||||
| Mortality Rate at DRG | 0.03 | ||||
| Mortality Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 12.52 | ||||
| SNF Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 14.16 | ||||
| Home Discharge Rate at DRG | 62.69 | ||||
| Home Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 57.08 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 359,935 | ||||
| Total Hospitalizations with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 106 | ||||
| DRG Share of Total Hospitalizations | 1.1 | ||||
| % of Total ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter in DRG | 1.04 | ||||
| Avg LOS at DRG | 12.3 | ||||
| Avg LOS with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 9.23 | ||||
| Readmission Rate at DRG | 16.01 | ||||
| Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 20.0 | ||||
| Unplanned Readmission Rate at DRG | 9.86 | ||||
| Unplanned Readmission Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 12.0 | ||||
| Total Medicare payments at DRG | $5,883,826,653 | ||||
| Total Medicare payments with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $1,109,447 | ||||
| Total Medicare payment per Day at DRG | $1,329 | ||||
| Total Medicare payment per Day with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $1,134 | ||||
| Total Medicare payment per Hospitalization at DRG | $16,347 | ||||
| Total Medicare payment per Hospitalization with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $10,466 | ||||
| Total Medicare Charges at DRG | $15,374,824,749 | ||||
| Total Medicare Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $4,327,819 | ||||
| Avg Charges at DRG | $42,716 | ||||
| Avg Charges with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | $40,828 | ||||
| Mortality Rate at DRG | 0.3 | ||||
| Mortality Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 27.95 | ||||
| SNF Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 36.79 | ||||
| Home Discharge Rate at DRG | 26.85 | ||||
| Home Discharge Rate with ICD T420X5A - Adverse effect of hydantoin derivatives, initial encounter | 25.47 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL HERMANN HOSPITAL SYSTEM | 1635 NORTH LOOP W | HOUSTON | TX | 77008 | 43 |
| METHODIST UNIVERSITY HOSPITAL | 1265 UNION AVE | MEMPHIS | TN | 38104 | 41 |
| MONTEFIORE MEDICAL CENTER | 111 E 210TH ST | BRONX | NY | 10467 | 30 |